The exports sales in US dollar terms of pharmaceutical company Sopharma marked a 121-percent year on year increase in February 2008. The sales revenue of the company for the same month went up by 44% compared to February 2007.

Sopharma's sales revenue for January and February 2008 went up by 24% compared to the corresponding period of 2007, including a 126-percent year on year increase in exports in US dollar terms.

Sopharma booked 362.753 million leva consoldated sales revenue for 2007, up 62% year on year.

The consolidated profit of the company for 2007 amounted to 31.719 million leva, which represents a 20.7-percent increase compared to 2006.

Major shareholders in Sopharma include Sofia AD (25.58%) , Telso AD (23.84%), Telecomplect AD (21.49%) and Gramercy Emerging Markets Fund (17.13 %).

A total of 1,727 shares in Sopharma traded hands on the Bulgarian Stock Exchange on Wednesday at an average prices of 7.15 leva apiece.